Forest Labs. Sues Seven Cos. Over Alzheimer's Drug

Law360, New York (January 11, 2008, 12:00 AM EST) -- Forest Laboratories has gone on the warpath against several companies including Teva Pharmaceuticals USA, Barr Laboratories Inc. and Lupin Ltd., in a bid to protect the lucrative market for the Alzheimer's drug Namenda from generic competition.

Forest and Merz Pharma GmbH & Co. KgaA filed two patent suits on Thursday in the U.S. District Court for the District of Delaware. One of the complaints names defendants including Teva, Lupin, Cobalt Laboratories Inc., Orchid Pharmaceuticals Inc., Upsher-Smith Laboratories Inc. and Wockhardt Limited. The other suit is against...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.